{
    "xml": "<topic id=\"PHP3951\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/primaquine\" basename=\"primaquine\" title=\"PRIMAQUINE\">\n<title>PRIMAQUINE</title>\n<body>\r\n<p outputclass=\"interactionsLinks\"> List of individual interactants: <xref format=\"dita\" href=\"#bnf_int_338\" namespace=\"/interactions/list-of-drug-interactions/antimalarials/primaquine\">Primaquine</xref>\n</p>\n<data name=\"vtmid\">36391008</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_397435873\" title=\"8-Aminoquinoline antimalarials\">8-Aminoquinoline antimalarials</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\r\n</body>\n<topic id=\"PHP40350\" outputclass=\"indicationsAndDose\" rev=\"1.20\" parent=\"/drugs/primaquine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunct in the treatment of non-falciparum malaria caused by <ph outputclass=\"organism\">\n<i>P.vivax</i>\n</ph> infection</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>30&#8239;mg daily for 14 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunct in the treatment of non-falciparum malaria caused by <ph outputclass=\"organism\">\n<i>P.ovale</i>\n</ph> infection</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>15&#8239;mg daily for 14 days.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunct in the treatment of non-falciparum malaria caused by <ph outputclass=\"organism\">\n<i>P.vivax</i>\n</ph> infection in patients with mild G6PD deficiency (administered on expert advice)</p>\n<p outputclass=\"therapeuticIndication\">Adjunct in the treatment of non-falciparum malaria caused by <ph outputclass=\"organism\">\n<i>P.ovale</i>\n</ph> infection in patients with mild G6PD deficiency (administered on expert advice)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>45&#8239;mg once weekly for 8 weeks.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Treatment of mild to moderate pneumocystis infection (in combination with clindamycin)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>30&#8239;mg daily, this combination is associated with considerable toxicity.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40313\" outputclass=\"unlicensedUse\" rev=\"1.12\" parent=\"/drugs/primaquine\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Not licensed.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40378\" outputclass=\"cautions\" rev=\"1.15\" parent=\"/drugs/primaquine\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">G6PD deficiency</ph>; <ph outputclass=\"caution\">systemic diseases associated with granulocytopenia (e.g. juvenile idiopathic arthritis, rheumatoid arthritis, lupus erythematosus)</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40345\" outputclass=\"interactions\" rev=\"1.7\" parent=\"/drugs/primaquine\">\n<title>Interactions</title>\n<body>\n<section outputclass=\"general\">\n<sectiondiv>\n<p>Appendix 1 (primaquine).</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40324\" outputclass=\"sideEffects\" rev=\"1.8\" parent=\"/drugs/primaquine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Haemolytic anaemia especially in G6PD deficiency</ph>; <ph outputclass=\"sideEffect\">leucopenia</ph>; <ph outputclass=\"sideEffect\">methaemoglobinaemia</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40342\" outputclass=\"pregnancy\" parent=\"/drugs/primaquine\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Risk of neonatal haemolysis and methaemoglobinaemia in third trimester.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40383\" outputclass=\"breastFeeding\" parent=\"/drugs/primaquine\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>No information available; theoretical risk of haemolysis in G6PD-deficient infants.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP40328\" outputclass=\"preTreatmentScreening\" rev=\"1.7\" parent=\"/drugs/primaquine\">\n<title>Pre-treatment screening</title>\n<body>\n<section>\n<sectiondiv>\n<p>Before starting primaquine, blood should be tested for glucose-6-phosphate dehydrogenase (G6PD) activity since the drug can cause haemolysis in G6PD-deficient patients. Specialist advice should be obtained in G6PD deficiency.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP3951-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/primaquine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral suspension</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76503\" title=\"Tablet\" namespace=\"/drugs/primaquine/tablet\">Tablet</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78098\" namespace=\"/treatment-summaries/antimalarials\" title=\"Antimalarials\" count=\"1\" rel=\"backlink\">Antimalarials</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78113\" namespace=\"/treatment-summaries/malaria-treatment\" title=\"Malaria, treatment\" count=\"3\" rel=\"backlink\">Malaria, treatment</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78452\" namespace=\"/treatment-summaries/pneumocystis-pneumonia\" title=\"Pneumocystis pneumonia\" count=\"1\" rel=\"backlink\">Pneumocystis pneumonia</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"interaction\" href=\"#bnf_int_338\" namespace=\"/interactions/list-of-drug-interactions/antimalarials/primaquine\" title=\"Primaquine\" count=\"1\" rel=\"link\">Primaquine</xref>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP76503\" namespace=\"/drugs/primaquine/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n</links>\n</topic>",
    "id": "PHP3951",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/primaquine",
    "basename": "primaquine",
    "title": "PRIMAQUINE",
    "interactants": [
        {
            "id": "bnf_int_338",
            "label": "Primaquine"
        }
    ],
    "vtmid": "36391008",
    "drugClassification": [
        "8-Aminoquinoline antimalarials"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Adjunct in the treatment of non-falciparum malaria caused by P.vivax infection",
                        "html": "Adjunct in the treatment of non-falciparum malaria caused by <ph outputclass=\"organism\"> <i>P.vivax</i> </ph> infection",
                        "organism": "P.vivax"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "P.vivax"
                },
                "adult": [
                    {
                        "textContent": "30 mg daily for 14 days.",
                        "html": "<p>30&#8239;mg daily for 14 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunct in the treatment of non-falciparum malaria caused by P.ovale infection",
                        "html": "Adjunct in the treatment of non-falciparum malaria caused by <ph outputclass=\"organism\"> <i>P.ovale</i> </ph> infection",
                        "organism": "P.ovale"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "P.ovale"
                },
                "adult": [
                    {
                        "textContent": "15 mg daily for 14 days.",
                        "html": "<p>15&#8239;mg daily for 14 days.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Adjunct in the treatment of non-falciparum malaria caused by P.vivax infection in patients with mild G6PD deficiency (administered on expert advice)",
                        "html": "Adjunct in the treatment of non-falciparum malaria caused by <ph outputclass=\"organism\"> <i>P.vivax</i> </ph> infection in patients with mild G6PD deficiency (administered on expert advice)",
                        "organism": "P.ovale"
                    },
                    {
                        "textContent": "Adjunct in the treatment of non-falciparum malaria caused by P.ovale infection in patients with mild G6PD deficiency (administered on expert advice)",
                        "html": "Adjunct in the treatment of non-falciparum malaria caused by <ph outputclass=\"organism\"> <i>P.ovale</i> </ph> infection in patients with mild G6PD deficiency (administered on expert advice)",
                        "organism": "P.ovale"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth",
                    "organism": "P.ovale"
                },
                "adult": [
                    {
                        "textContent": "45 mg once weekly for 8 weeks.",
                        "html": "<p>45&#8239;mg once weekly for 8 weeks.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Treatment of mild to moderate pneumocystis infection (in combination with clindamycin)",
                        "html": "Treatment of mild to moderate pneumocystis infection (in combination with clindamycin)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "30 mg daily, this combination is associated with considerable toxicity.",
                        "html": "<p>30&#8239;mg daily, this combination is associated with considerable toxicity.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Not licensed.",
                "html": "<p>Not licensed.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "G6PD deficiency",
                "html": "G6PD deficiency"
            },
            {
                "type": "cautions",
                "textContent": "systemic diseases associated with granulocytopenia (e.g. juvenile idiopathic arthritis, rheumatoid arthritis, lupus erythematosus)",
                "html": "systemic diseases associated with granulocytopenia (e.g. juvenile idiopathic arthritis, rheumatoid arthritis, lupus erythematosus)"
            }
        ]
    },
    "interactions": {
        "general": [
            {
                "type": "general",
                "textContent": "Appendix 1 (primaquine).",
                "html": "<p>Appendix 1 (primaquine).</p>"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "anorexia",
                        "html": "anorexia",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    },
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Haemolytic anaemia especially in G6PD deficiency",
                        "html": "Haemolytic anaemia especially in G6PD deficiency",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "leucopenia",
                        "html": "leucopenia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "methaemoglobinaemia",
                        "html": "methaemoglobinaemia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Risk of neonatal haemolysis and methaemoglobinaemia in third trimester.",
                "html": "<p>Risk of neonatal haemolysis and methaemoglobinaemia in third trimester.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "No information available; theoretical risk of haemolysis in G6PD-deficient infants.",
                "html": "<p>No information available; theoretical risk of haemolysis in G6PD-deficient infants.</p>"
            }
        ]
    },
    "preTreatmentScreening": {
        "preTreatmentScreening": [
            {
                "type": "preTreatmentScreening",
                "textContent": "Before starting primaquine, blood should be tested for glucose-6-phosphate dehydrogenase (G6PD) activity since the drug can cause haemolysis in G6PD-deficient patients. Specialist advice should be obtained in G6PD deficiency.",
                "html": "<p>Before starting primaquine, blood should be tested for glucose-6-phosphate dehydrogenase (G6PD) activity since the drug can cause haemolysis in G6PD-deficient patients. Specialist advice should be obtained in G6PD deficiency.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral suspension"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP76503",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78098",
                "label": "Antimalarials",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78113",
                "label": "Malaria, treatment",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78452",
                "label": "Pneumocystis pneumonia",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "interaction": [
            {
                "id": "bnf_int_338",
                "label": "Primaquine",
                "type": "interaction"
            }
        ],
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP76503",
                "label": "Tablet",
                "type": "medicinalForm"
            }
        ]
    }
}